Navigation Links
Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
Date:9/17/2009

or the first time, we have a treatment option in one pill that targets two key points of the RAAS, which may be overactive in many hypertensive patients."

This approval was primarily based on a pivotal eight-week randomized, double-blind, placebo-controlled clinical trial in approximately 1,800 patients, which studied aliskiren 150 mg and 300 mg and valsartan 160 mg and 320 mg alone and in combination. The initial doses of aliskiren and valsartan were 150 mg and 160 mg, respectively, and were increased at four weeks to 300 mg and 320 mg, respectively. Blood pressure reductions with the aliskiren/valsartan combination were significantly greater than with the monotherapies or placebo at the eight-week primary endpoint. Mean systolic and diastolic blood pressure reductions from baseline were 17.2/12.2 mmHg for aliskiren 300 mg/valsartan 320 mg, compared with 12.8/9.7 mmHg for valsartan 320 mg, 13.0/9.0 mmHg for aliskiren 300 mg, and 4.6/4.1 mmHg for placebo (p<0.05 for aliskiren/valsartan vs monotherapies or placebo).

The single-pill combination Valturna targets the RAAS in two ways. The valsartan component blocks, at the receptor level, the action of angiotensin II, an important end product of the RAAS that causes blood vessels to tighten and narrow. The aliskiren component reduces angiotensin II levels by directly inhibiting renin, an enzyme produced by the kidneys that starts a process which leads to formation of angiotensin II. An overactive RAAS is an important contributor to high blood pressure in many patients. By targeting two key points within the RAAS, Valturna helps blood vessels relax and widen so blood pressure is lowered.

Research suggests that up to 85% of hypertensive patients may need multiple medications to help control their blood pressure, underscoring the need for effective combination treatments.

High blood pressure affects approximately 74 million, or nearly one in thr
'/>"/>

SOURCE Novartis
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine news :

1. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
2. Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension
3. Video: Novartis Receives Approval From FDA to Market Prevacid(R) 24HR as First and Only OTC Proton Pump Inhibitor in Original Prescription Formulation
4. J&J, Schering-Plough, Novartis, Bayer vie for Top Honors at the Premier OTC / Healthcare Ad Awards
5. Novartis Oncology Launches GIST Alliance&#8482; for Patients and Caregivers
6. Novartis Oncology Launches GIST Alliance&#8482; for Healthcare Professionals Treating Gastrointestinal Stromal Tumors
7. Gen-Probe and Novartis Agree to Extend and Expand Blood Screening Collaboration
8. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity
9. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
10. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
11. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... Case Medical Center clinical researchers have launched an ... will evaluate the ability of a patient,s own ... stage peripheral arterial disease (PAD). , Led ... at University Hospitals Case Medical Center,s Harrington Heart ... Case Western Reserve University School of Medicine, the ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 The July 2013 ... Cheater’s Guide to Getting Beach Ready,” offers a list of ... look their best in a bathing suit this summer. The ... skin firming , smoothing cellulite , and more. (go ... Ourian, Medical Director of Epione Beverly Hills, “though I would ...
(Date:6/18/2013)... Healthcare Solutions , the parent ... today announced the appointment of Richard Leonardo to ... position, Leonardo will direct Healthcare Solutions’ national sales ... initiatives. , Recognized in the property and casualty ... more than 20 years of experience in business ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 David Connett, ... of Family Medicine for the College of Osteopathic Medicine ... Sciences has been elected president of the Osteopathic ... G. Brown Jr. appointed Connett, a 1984 alumnus of ... members recently elected Connett to the position during a ...
(Date:6/18/2013)... fat cells in the mammary gland appear to provide ... early in life, and the subsequent development of breast ... the July 2013 issue of the journal Cancer ... may be associated with an increased risk of certain ... the biology of social stress to cancer have been ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4
... fatty liver disease (NAFLD) and non-alcoholic steatohepatitis ... disease leading to cirrhosis and hepatocellular carcinoma. ... significant efficacy in these conditions and no ... the renin-angiotensin system overexpression plays a central ...
... and family can pave the way to sporting victory, according ... Kelly Holmes and Sir Chris Hoy have both cited the ... factor in their Olympic success. Now, for the first time, ... on sports performance. , Published in the Journal ...
... Jeff Bingaman (D-NM) received the 2009 Outstanding Leadership ... (APAPO) for his advocacy work and legislative accomplishments ... given to a member of Congress who has ... Bingaman has been a tireless crusader of mental ...
... in the Diagnosis and Assessment of AsthmaEXTON, Pa., March ... Pharmaxis Ltd (ASX: PXS, Nasdaq: PXSL ), ... it has filed a New Drug Application (NDA), electronically, ... Aridol(TM) (mannitol bronchial challenge test). Bronchial challenge tests ...
... B. Snow Jr., chairman and chief executive officer, Medco ... scheduled to address the Barclays Capital Global Healthcare Conference ... the Loews Miami Beach Hotel, South Beach, will begin ... officer, is also scheduled to attend.The presentation may be ...
... Specially trained vets are using ancient treatment to fight ... After surgery for a ruptured disk two years ago, ... became lethargic and lost her appetite. , Things were ... 10-year-old to an acupuncturist, who treated her three times ...
Cached Medicine News:Health News:Is telmisartan effective in treating non-alcoholic steatohepatitis? 2Health News:Is telmisartan effective in treating non-alcoholic steatohepatitis? 3Health News:Study shows why sporting heroes should thank their friends 2Health News:Pharmaxis Announces NDA Filing for Aridol(TM) (Mannitol Bronchial Challenge Test) 2Health News:Medco CEO to Present at the Barclays Capital Global Healthcare Conference 2Health News:Animals Respond to Acupuncture's Healing Touch 2Health News:Animals Respond to Acupuncture's Healing Touch 3Health News:Animals Respond to Acupuncture's Healing Touch 4
(Date:6/17/2013)... PAUL, Minn. , June 17, 2013 Prime ... branding and design agency, Larsen, was awarded the Silver Anvil ... Repositioning Prime Therapeutics." The award was presented at the Public ... Ceremony held June 13 at the AXA Equitable ... The Silver Anvil, which has been presented annually ...
(Date:6/17/2013)... , June 17, 2013 /PRNewswire-iReach/ -- Weiler ... company,s new X-4S pressure sensitive labeling head. The ... speed and performance requirements that serialization demands. ... WLS is uniquely qualified to work with pharmaceutical ... their serialization and track and trace implementation strategies. ...
(Date:6/17/2013)... Mass. and TORONTO , ... ) (OTCBB:GNBT) today announced that it entered into a ... 17, 2013.  The investors have agreed to purchase in ... the Company,s newly designated non-voting Series E 9% Convertible ... up to an aggregate of 100% of the shares ...
Breaking Medicine Technology:Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2Generex Announces $1,225,000 Capital Investment 2Generex Announces $1,225,000 Capital Investment 3Generex Announces $1,225,000 Capital Investment 4Generex Announces $1,225,000 Capital Investment 5
... 2011  IRIDEX Corporation (Nasdaq: IRIX ) today ... 10 years demonstrates the safety and efficacy of MicroPulse ... the retina tissue damage associated with conventional laser therapy.  ... and Prevention, DME, a swelling of retinal tissue, is ...
... Reportlinker.com announces that a new market ... Global Medical Ultrasound ... http://www.reportlinker.com/p098401/Global-Medical-Ultrasound-Equipment-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_I This report analyzes ... in US$ Million by the following End-Use ...
Cached Medicine Technology:10-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema 210-Year Study Demonstrates IRIDEX MicroPulse™ Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema 3Global Medical Ultrasound Equipment Industry 2Global Medical Ultrasound Equipment Industry 3Global Medical Ultrasound Equipment Industry 4Global Medical Ultrasound Equipment Industry 5Global Medical Ultrasound Equipment Industry 6Global Medical Ultrasound Equipment Industry 7Global Medical Ultrasound Equipment Industry 8Global Medical Ultrasound Equipment Industry 9Global Medical Ultrasound Equipment Industry 10Global Medical Ultrasound Equipment Industry 11Global Medical Ultrasound Equipment Industry 12Global Medical Ultrasound Equipment Industry 13Global Medical Ultrasound Equipment Industry 14Global Medical Ultrasound Equipment Industry 15Global Medical Ultrasound Equipment Industry 16Global Medical Ultrasound Equipment Industry 17Global Medical Ultrasound Equipment Industry 18Global Medical Ultrasound Equipment Industry 19Global Medical Ultrasound Equipment Industry 20Global Medical Ultrasound Equipment Industry 21Global Medical Ultrasound Equipment Industry 22Global Medical Ultrasound Equipment Industry 23Global Medical Ultrasound Equipment Industry 24Global Medical Ultrasound Equipment Industry 25
Bi-Directional doppler volume flowmeter....
... frequency and multigate transcranial ... and fitted with a ... for hemodynamic evaluation. Looki ... well for routine diagnosis ...
One channel, one gate transcranial Doppler that is diagnosis oriented with an advanced protocol editor, automatic report generator and a powerful examination data base....
One channel transcranial Doppler...
Medicine Products: